Takeda Pharmaceutical Co Stock Filter Stocks by Fundamentals
TKPHF Stock | USD 25.77 0.75 2.83% |
Takeda Pharmaceutical Co fundamentals help investors to digest information that contributes to Takeda Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Takeda Pink Sheet. The fundamental analysis module provides a way to measure Takeda Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Takeda Pharmaceutical pink sheet.
Takeda |
Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
All Next | Launch Module |
Takeda Fundamentals
Return On Equity | 0.0477 | |||
Return On Asset | 0.0247 | |||
Profit Margin | 0.07 % | |||
Operating Margin | 0.13 % | |||
Current Valuation | 75.53 B | |||
Shares Outstanding | 1.56 B | |||
Shares Owned By Insiders | 1.20 % | |||
Shares Owned By Institutions | 41.35 % | |||
Price To Earning | 27.54 X | |||
Price To Book | 0.97 X | |||
Price To Sales | 0.01 X | |||
Revenue | 3.57 T | |||
Gross Profit | 2.44 T | |||
EBITDA | 1.05 T | |||
Net Income | 230.06 B | |||
Cash And Equivalents | 645.99 B | |||
Cash Per Share | 417.82 X | |||
Total Debt | 4.14 T | |||
Debt To Equity | 0.81 % | |||
Current Ratio | 1.18 X | |||
Book Value Per Share | 3,973 X | |||
Cash Flow From Operations | 1.12 T | |||
Earnings Per Share | 1.33 X | |||
Price To Earnings To Growth | 0.58 X | |||
Number Of Employees | 47.35 K | |||
Beta | 0.7 | |||
Market Capitalization | 50.37 B | |||
Total Asset | 13.18 T | |||
Retained Earnings | 1.57 T | |||
Working Capital | 675.58 B | |||
Current Asset | 1.48 T | |||
Current Liabilities | 808.72 B | |||
Annual Yield | 0.04 % | |||
Five Year Return | 3.99 % | |||
Net Asset | 13.18 T | |||
Last Dividend Paid | 180.0 |
About Takeda Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Takeda Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Takeda Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Takeda Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Takeda Pharmaceutical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Takeda Pink Sheet is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Takeda Pharmaceutical Co Stock. Highlighted below are key reports to facilitate an investment decision about Takeda Pharmaceutical Co Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Takeda Pharmaceutical Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Takeda Pharmaceutical information on this page should be used as a complementary analysis to other Takeda Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Takeda Pink Sheet analysis
When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Stocks Directory Find actively traded stocks across global markets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |